Below are the most recent publications written about "Parkinson Disease" by people in Profiles.
-
Isaacson SH, Kremens D, Torres-Yaghi Y, Stocchi F, Antonini A. Importance of time to ON versus wearing OFF in total daily OFF time experienced by patients with Parkinson's disease. Parkinsonism Relat Disord. 2023 09; 114:105495.
-
Schneider JS. GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson's Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson's Disease-Relevant Pathogenic Mechanisms. Int J Mol Sci. 2023 May 24; 24(11).
-
Thompson ED, Reisman DS. Split-Belt Adaptation and Savings in People With Parkinson Disease. J Neurol Phys Ther. 2022 10 01; 46(4):293-301.
-
Osborne JA, Botkin R, Colon-Semenza C, DeAngelis TR, Gallardo OG, Kosakowski H, Martello J, Pradhan S, Rafferty M, Readinger JL, Whitt AL, Ellis TD. Physical Therapist Management of Parkinson Disease: A Clinical Practice Guideline From the American Physical Therapy Association. Phys Ther. 2022 04 01; 102(4).
-
Pringsheim T, Day GS, Smith DB, Rae-Grant A, Licking N, Armstrong MJ, de Bie RMA, Roze E, Miyasaki JM, Hauser RA, Espay AJ, Martello JP, Gurwell JA, Billinghurst L, Sullivan K, Fitts MS, Cothros N, Hall DA, Rafferty M, Hagerbrant L, Hastings T, O'Brien MD, Silsbee H, Gronseth G, Lang AE. Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee. Neurology. 2021 11 16; 97(20):942-957.
-
Hollern DA, Shah NV, Moattari CR, Lavian JD, Akil S, Beyer GA, Najjar S, Desai R, Zuchelli DM, Schroeder GD, Passias PG, Hilibrand AS, Vaccaro AR, Schwab FJ, Lafage V, Paulino CB, Diebo BG. Outcomes of Patients With Parkinson Disease Undergoing Cervical Spine Surgery for Radiculopathy and Myelopathy With Minimum 2-Year Follow-up. Clin Spine Surg. 2021 10 01; 34(8):E432-E438.
-
Chou KL, Martello J, Atem J, Elrod M, Foster ER, Freshwater K, Gunzler SA, Kim H, Mahajan A, Sarva H, Stebbins GT, Lee E, Yang L. Quality Improvement in Neurology: 2020 Parkinson Disease Quality Measurement Set Update. Neurology. 2021 08 03; 97(5):239-245.
-
Buccafusca M, Micali C, Autunno M, Versace AG, Nunnari G, Musumeci O. Favourable course in a cohort of Parkinson's disease patients infected by SARS-CoV-2: a single-centre experience. Neurol Sci. 2021 Mar; 42(3):811-816.
-
Schneider RB, Myers TL, Rowbotham HM, Luff MK, Amodeo K, Sharma S, Wilson R, Jensen-Roberts S, Auinger P, McDermott MP, Alcalay RN, Biglan K, Kinel D, Tanner C, Winter-Evans R, Augustine EF, Cannon P, Holloway RG, Dorsey ER. A Virtual Cohort Study of Individuals at Genetic Risk for Parkinson's Disease: Study Protocol and Design. J Parkinsons Dis. 2020; 10(3):1195-1207.
-
Horning MA, Shin JY, DiFusco LA, Norton M, Habermann B. Symptom progression in advanced Parkinson's disease: Dyadic perspectives. Appl Nurs Res. 2019 12; 50:151193.